Companies: 10,795·Total market cap: $144.5T
DNAPrint Genomics, Inc.

DNAPrint Genomics, Inc.

DNAGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$12892
P/E Ratio
52W High$0.00002
52W Low$0.000001
Overview

DNAPrint Genomics, Inc.(DNAG)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DNAG · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2006-122005-122004-122003-122002-12
Revenue
Revenue$2.43M$1.28M$0.79M$0.71M$0.18M
Cost of Revenue$1.68M$0.95M$0.51M$0.43M$0.07M
Gross Profit$0.75M$0.33M$0.28M$0.28M$0.11M
Gross Margin %(computed)30.99%25.48%35.35%39.09%60.33%
Operating Expenses
R&D Expenses$6.43M$2.12M$1.56M$2.65M$2.20M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses($8.11M)($4.34M)($3.06M)($5.96M)($2.50M)
Operating Income($8.87M)($4.66M)$3.33M$6.23M$2.61M
Operating Margin %(computed)-364.45%-365.50%424.42%878.58%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax$0.00M$0.00M$0.00M$0.00M$0.00M
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($12.35M)($8.72M)($3.73M)($7.79M)($3.11M)
Net Margin %(computed)-507.54%-683.33%-475.41%
Per Share & EBITDA
EPS (Basic)$-0.03$-0.09$-0.20$-3.20$-0.14
Wtd Avg Shares365.24M93.53M35.37M24.98M22.57M
EBITDA($8.93M)($2.38M)($2.28M)($5.19M)($2.16M)
EBITDA Margin %(computed)-367.02%-186.25%-290.55%-732.03%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解DNAPrint Genomics, Inc.

关于DNAPrint Genomics, Inc.(DNAG)损益表

DNAPrint Genomics, Inc.(DNAG)损益表数据来源于SEC Form 10-K及10-Q申报文件。2006财年,DNAG实现营收$0.00B,毛利润$0.00B(毛利率30.99%),净利润($0.01B)(净利率-507.54%)。

常见问题

DNAG · 4 问

DNAPrint Genomics, Inc.(DNAG)2006财年营收为$0.00B,同比up90.7%。

DNAG revenueDNAG salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09